Pharma & Health Business News

• 2019-09-22
• Amgen to buy Celgene’s Otezla in $13.4bn deal
• Source: Financial Times - Permalink
2019-09-04
• J&J ordered to pay $572m in opioid trial
• Source: Financial Times - Permalink
• Biotech companies issue first declaration on human gene editing
• Source: Financial Times - Permalink
• FT Health: Communicable Diseases
• Source: Financial Times - Permalink
• US health leaders play the anti-vaxxers at their own game
• Source: Financial Times - Permalink
• Biotechs fight fears of ‘antibiotic apocalypse’
• Source: Financial Times - Permalink
• Japanese clinical trials can help check western domination
• Source: Financial Times - Permalink
• Japan’s GHIT ramps up fight against neglected diseases
• Source: Financial Times - Permalink
• Community health workers’ focus on prevention brings dividends
• Source: Financial Times - Permalink
• Debate over vaccination strategies dogs Ebola efforts in Congo
• Source: Financial Times - Permalink
• Vaccines ‘most powerful tool against infectious diseases’
• Source: Financial Times - Permalink
• Gene editing: even Crispr 
• Source: Financial Times - Permalink
• J&J verdict hits share prices across opioid industry
• Source: Financial Times - Permalink
• Edited genes are not ready to be inherited
• Source: Financial Times - Permalink
• Purdue and Sacklers offer opioid settlement of up to $12bn
• Source: Financial Times - Permalink
• We cannot win the drugs war by limiting supply
• Source: Financial Times - Permalink
• Purdue/opioids: this is going to hurt
• Source: Financial Times - Permalink
• Prices tumble for debt backing KKR’s $9.9bn Envision buyout
• Source: Financial Times - Permalink
• Breast cancer risk from HRT is double previous estimate, finds study
• Source: Financial Times - Permalink
• Litigation alone cannot heal the opioid epidemic
• Source: Financial Times - Permalink
• Juul increases debt offering amid FDA review
• Source: Financial Times - Permalink
• Verily’s all-out war on disease seeks healthy returns
• Source: Financial Times - Permalink
• Cell therapy results ‘very promising’ in children with cancer
• Source: Financial Times - Permalink
• UK biotech seals £100m funding for lung cancer trials
• Source: Financial Times - Permalink
• Novartis executive sold $1m shares ahead of probe
• Source: Financial Times - Permalink
2019-08-26
• Juul raises $325m in fresh funding
• Source: Financial Times - Permalink
• Search for motor neurone disease cure gathers pace
• Source: Financial Times - Permalink
• Bayer agrees $7.6bn sale of animal health business to Elanco
• Source: Financial Times - Permalink
• Nigeria to be last African nation declared polio-free
• Source: Financial Times - Permalink
• AstraZeneca faces setback in lung cancer drug trial
• Source: Financial Times - Permalink
• Powell Jobs-backed start-up to offer ‘genetic counselling’
• Source: Financial Times - Permalink
• Gilead to challenge US patents on HIV drug Truvada
• Source: Financial Times - Permalink
• NMC Health shares jump on report of Chinese interest in stake
• Source: Financial Times - Permalink
• NMC Health: sick note
• Source: Financial Times - Permalink
• Daily ‘polypill’ cuts risk of heart disease
• Source: Financial Times - Permalink
• J&J faces court judgment over opioids crisis
• Source: Financial Times - Permalink
• HMRC targets GSK contractors in tax crackdown
• Source: Financial Times - Permalink
• Eastern Europe sees sharp rise in swine fever outbreaks
• Source: Financial Times - Permalink
2019-08-19
• US patients struggle to obtain Eli Lilly’s half-price insulin
• Source: Financial Times - Permalink
• Ebola drugs trial raises prospect of cure
• Source: Financial Times - Permalink
• JPMorgan set to scoop record fee for Allergan sale
• Source: Financial Times - Permalink
• NHS wins first payment over anti-competitive practice
• Source: Financial Times - Permalink
• Health ministry acts to ensure Brexit medicines supply
• Source: Financial Times - Permalink
• Novartis ousted scientists before reporting data manipulation
• Source: Financial Times - Permalink
• Gilead did not seek US exclusivity on PrEP with Truvada
• Source: Financial Times - Permalink
• Juvenescence raises another $100m to invest in longevity
• Source: Financial Times - Permalink
• How digital services are transforming UK mental healthcare
• Source: Financial Times - Permalink
• Pending litigation weighs on Teva
• Source: Financial Times - Permalink
2019-08-09
• Unions threaten legal challenge over pension measures
• Source: Financial Times - Permalink
• NHS looks to artificial intelligence to improve health
• Source: Financial Times - Permalink